Cargando…
Molecular Mapping of Urinary Complement Peptides in Kidney Diseases
Defective complement activation has been associated with various types of kidney disease. This led to the hypothesis that specific urine complement fragments may be associated with kidney disease etiologies, and disease progression may be reflected by changes in these complement fragments. We invest...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709096/ https://www.ncbi.nlm.nih.gov/pubmed/34941814 http://dx.doi.org/10.3390/proteomes9040049 |
_version_ | 1784622850063204352 |
---|---|
author | Wendt, Ralph Siwy, Justyna He, Tianlin Latosinska, Agnieszka Wiech, Thorsten Zipfel, Peter F. Tserga, Aggeliki Vlahou, Antonia Rupprecht, Harald Catanese, Lorenzo Mischak, Harald Beige, Joachim |
author_facet | Wendt, Ralph Siwy, Justyna He, Tianlin Latosinska, Agnieszka Wiech, Thorsten Zipfel, Peter F. Tserga, Aggeliki Vlahou, Antonia Rupprecht, Harald Catanese, Lorenzo Mischak, Harald Beige, Joachim |
author_sort | Wendt, Ralph |
collection | PubMed |
description | Defective complement activation has been associated with various types of kidney disease. This led to the hypothesis that specific urine complement fragments may be associated with kidney disease etiologies, and disease progression may be reflected by changes in these complement fragments. We investigated the occurrence of complement fragments in urine, their association with kidney function and disease etiology in 16,027 subjects, using mass spectrometry based peptidomics data from the Human Urinary Proteome/Peptidome Database. Twenty-three different urinary peptides originating from complement proteins C3, C4 and factor B (CFB) could be identified. Most C3-derived peptides showed inverse association with estimated glomerular filtration rate (eGFR), while the majority of peptides derived from CFB demonstrated positive association with eGFR. Several peptides derived from the complement proteins C3, C4 and CFB were found significantly associated with specific kidney disease etiologies. These peptides may depict disease-specific complement activation and could serve as non-invasive biomarkers to support development of complement interventions through assessing complement activity for patients’ stratification and monitoring of drug impact. Further investigation of these complement peptides may provide additional insight into disease pathophysiology and could possibly guide therapeutic decisions, especially when targeting complement factors. |
format | Online Article Text |
id | pubmed-8709096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87090962021-12-25 Molecular Mapping of Urinary Complement Peptides in Kidney Diseases Wendt, Ralph Siwy, Justyna He, Tianlin Latosinska, Agnieszka Wiech, Thorsten Zipfel, Peter F. Tserga, Aggeliki Vlahou, Antonia Rupprecht, Harald Catanese, Lorenzo Mischak, Harald Beige, Joachim Proteomes Article Defective complement activation has been associated with various types of kidney disease. This led to the hypothesis that specific urine complement fragments may be associated with kidney disease etiologies, and disease progression may be reflected by changes in these complement fragments. We investigated the occurrence of complement fragments in urine, their association with kidney function and disease etiology in 16,027 subjects, using mass spectrometry based peptidomics data from the Human Urinary Proteome/Peptidome Database. Twenty-three different urinary peptides originating from complement proteins C3, C4 and factor B (CFB) could be identified. Most C3-derived peptides showed inverse association with estimated glomerular filtration rate (eGFR), while the majority of peptides derived from CFB demonstrated positive association with eGFR. Several peptides derived from the complement proteins C3, C4 and CFB were found significantly associated with specific kidney disease etiologies. These peptides may depict disease-specific complement activation and could serve as non-invasive biomarkers to support development of complement interventions through assessing complement activity for patients’ stratification and monitoring of drug impact. Further investigation of these complement peptides may provide additional insight into disease pathophysiology and could possibly guide therapeutic decisions, especially when targeting complement factors. MDPI 2021-12-13 /pmc/articles/PMC8709096/ /pubmed/34941814 http://dx.doi.org/10.3390/proteomes9040049 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wendt, Ralph Siwy, Justyna He, Tianlin Latosinska, Agnieszka Wiech, Thorsten Zipfel, Peter F. Tserga, Aggeliki Vlahou, Antonia Rupprecht, Harald Catanese, Lorenzo Mischak, Harald Beige, Joachim Molecular Mapping of Urinary Complement Peptides in Kidney Diseases |
title | Molecular Mapping of Urinary Complement Peptides in Kidney Diseases |
title_full | Molecular Mapping of Urinary Complement Peptides in Kidney Diseases |
title_fullStr | Molecular Mapping of Urinary Complement Peptides in Kidney Diseases |
title_full_unstemmed | Molecular Mapping of Urinary Complement Peptides in Kidney Diseases |
title_short | Molecular Mapping of Urinary Complement Peptides in Kidney Diseases |
title_sort | molecular mapping of urinary complement peptides in kidney diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709096/ https://www.ncbi.nlm.nih.gov/pubmed/34941814 http://dx.doi.org/10.3390/proteomes9040049 |
work_keys_str_mv | AT wendtralph molecularmappingofurinarycomplementpeptidesinkidneydiseases AT siwyjustyna molecularmappingofurinarycomplementpeptidesinkidneydiseases AT hetianlin molecularmappingofurinarycomplementpeptidesinkidneydiseases AT latosinskaagnieszka molecularmappingofurinarycomplementpeptidesinkidneydiseases AT wiechthorsten molecularmappingofurinarycomplementpeptidesinkidneydiseases AT zipfelpeterf molecularmappingofurinarycomplementpeptidesinkidneydiseases AT tsergaaggeliki molecularmappingofurinarycomplementpeptidesinkidneydiseases AT vlahouantonia molecularmappingofurinarycomplementpeptidesinkidneydiseases AT rupprechtharald molecularmappingofurinarycomplementpeptidesinkidneydiseases AT cataneselorenzo molecularmappingofurinarycomplementpeptidesinkidneydiseases AT mischakharald molecularmappingofurinarycomplementpeptidesinkidneydiseases AT beigejoachim molecularmappingofurinarycomplementpeptidesinkidneydiseases |